Who are the peers of the Zota Health Care?
Zota Health Care's peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, and others. In terms of management risk, growth, and capital structure, Sun Pharma and Cipla show excellent performance, while Zota Health Care has below average capital structure and a 1-year return of 0.00%.
Peers: The peers of Zota Health Care are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, IOL Chemicals, Novartis India, Indoco Remedies, Senores Pharma., and SMS Pharma.Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Cipla, Dr Reddy's Labs, and the rest. Good management risk is found at Divi's Lab., Torrent Pharma, and the rest. Average management risk is present at IOL Chemicals, Novartis India, Indoco Remedies, SMS Pharma., and the rest. Below average management risk is noted at Senores Pharma. Growth is excellent at Sun Pharma.Inds., Cipla, Dr Reddy's Labs, and the rest, while below average growth is seen at Divi's Lab., Torrent Pharma, IOL Chemicals, Indoco Remedies, SMS Pharma., and the rest. Good growth is found at Novartis India, and excellent growth is noted at Senores Pharma. Capital structure is excellent at Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs, and the rest, while good capital structure is observed at Torrent Pharma, and average capital structure is found at IOL Chemicals, Indoco Remedies, SMS Pharma., and the rest. Below average capital structure is noted at Zota Health Care.
Return Snapshot: Divi's Lab. has the highest 1-year return at 51.96%, while Cipla has the lowest at 0.86%. Zota Health Care's 1-year return is 0.00%, which is lower than both. Additionally, IOL Chemicals and Indoco Remedies have negative six-month returns.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
